Is nab-paclitaxel better than conventional taxanes as neoadjuvant therapy for breast cancer? A meta-analysis

OBJECTIVE: This study compared the efficacy and safety of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) with conventional taxanes as neoadjuvant chemotherapy for breast cancer. METHODS: We searched the literature using PubMed, the Cochrane Library, and Web of Science from their inception to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong, Lu, Xiaoju, Lin, Qimou, Li, Weiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416144/
https://www.ncbi.nlm.nih.gov/pubmed/32762463
http://dx.doi.org/10.1177/0300060520943473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416144/
https://www.ncbi.nlm.nih.gov/pubmed/32762463
http://dx.doi.org/10.1177/0300060520943473

Ejemplares similares